Endocrine-Related Cancer

References

1. ↵
   1. Abraham SC,
   2. Carney JA,
   3. Ooi A,
   4. Choti MA &
   5. Argani P

   2005 Achlorhydria, parietal cell hyperplasia, and multiple gastric carcinoids. A new disorder. American Journal of Surgical Pathology 29 969–975. doi:10.1097/01.pas.0000163363.86099.9f.
2. ↵
   1. Anlauf M,
   2. Perren A,
   3. Meyer CL,
   4. Schmid S,
   5. Saremaslani P,
   6. Kruse ML,
   7. Weihe E,
   8. Komminoth P,
   9. Heitz PU &
   10. Klöppel G

   2005 Endocrine precursor lesions are associated with duodenal gastrinomas in patients suffering from multiple endocrine neoplasia type 1. Gastroenterology 128 1187–1198.
3. ↵
   1. Anlauf M,
   2. Garbrecht N,
   3. Henopp T,
   4. Schmitt A,
   5. Schlenger R,
   6. Raffel A,
   7. Krausch M,
   8. Gimm O,
   9. Eisenberger CF,
   10. Knoefel WT
   11. et al.

   2006a Sporadic versus hereditary gastrinomas of the duodenum and pancreas: distinct clinico-pathological and epidemiological features. World Journal of Gastroenterology 12 5440–5446.
4. ↵
   1. Anlauf M,
   2. Schlenger R,
   3. Perren A,
   4. Bauersfeld J,
   5. Koch CA,
   6. Dralle H,
   7. Raffel A,
   8. Knoefel WT,
   9. Weihe E,
   10. Ruszniewski P
   11. et al.

   2006b Microadenomatosis of the endocrine pancreas in patients with and without the multiple endocrine neoplasia type 1 syndrome. American Journal of Surgical Pathology 30 560–574. doi:10.1097/01.pas.0000194044.01104.25.
5. ↵
   1. Anlauf M,
   2. Garbrecht N,
   3. Schmitt A,
   4. Henopp T,
   5. Komminoth P,
   6. Heitz PU,
   7. Perren A &
   8. Klöppel G

   2007a Hereditary neuroendocrine tumors of the gastroenteropancreatic system. Virchows Archiv 451 (Supplement 1) S29–S38. doi:10.1007/s00428-007-0450-3.
6. ↵
   1. Anlauf M,
   2. Perren A,
   3. Henopp T,
   4. Rudolph T,
   5. Garbrecht N,
   6. Schmitt A,
   7. Raffel A,
   8. Gimm O,
   9. Weihe E,
   10. Knoefel WT
   11. et al.

   2007b Allelic deletion of the MEN1 gene in duodenal gastrin and somatostatin cell neoplasms and their precursor lesions. Gut 56 637–644. doi:10.1136/gut.2006.108910.
7. ↵
   1. Anlauf M,
   2. Enosawa T,
   3. Henopp T,
   4. Schmitt A,
   5. Gimm O,
   6. Brauckhoff M,
   7. Dralle H,
   8. Musil A,
   9. Hauptmann S,
   10. Perren A
   11. et al.

   2008 Primary lymph node gastrinoma or occult duodenal microgastrinoma with lymph node metastases in a MEN1 patient: the need for a systematic search for the primary tumor. American Journal of Surgical Pathology 32 1101–1105. doi:10.1097/PAS.0b013e3181655811.
8. ↵
   1. Anlauf M,
   2. Bauersfeld J,
   3. Raffael A,
   4. Koch CA,
   5. Henopp T,
   6. Alkatout I,
   7. Schmitt A,
   8. Weber A,
   9. Kruse ML,
   10. Braunstein S
   11. et al.

   2009 Insulinomatosis: a multicentric insulinoma disease that frequently causes early recurrent hyperinsulinemic hypoglycemia. American Journal of Surgical Pathology 33 339–346. doi:10.1097/PAS.0b013e3181874eca.
9. ↵
   1. Anthony LB,
   2. Strosberg JR,
   3. Klimstra DS,
   4. Maples WJ,
   5. O'Dorisio TM,
   6. Warner RR,
   7. Wiseman GA,
   8. Benson AB III. &
   9. Pommier RF

   2010 The NANETS consensus guidelines for the diagnosis and management of gastrointestinal neuroendocrine tumors (NETs): well-differentiated nets of the distal colon and rectum. Pancreas 39 767–774. doi:10.1097/MPA.0b013e3181ec1261.
10. ↵
    1. Berardi RS

    1972 Carcinoid tumors of the colon (exclusive of the rectum): review of the literature. Diseases of the Colon and Rectum 15 383–391. doi:10.1007/BF02587418.
11. ↵
    1. Berger G,
    2. Trouillas J,
    3. Bloch B,
    4. Sassolas G,
    5. Berger F,
    6. Partensky C,
    7. Chayvialle JA,
    8. Brazeau P,
    9. Claustrat B,
    10. Lesbros F
    11. et al.

    1984 Multihormonal carcinoid tumor of the pancreas. Secreting growth hormone-releasing factor as a cause of acromegaly. Cancer 54 2097–2108. doi:10.1002/1097-0142(19841115)54:10<2097::AID-CNCR2820541009>3.0.CO;2-X.
12. ↵
    1. Bordi C,
    2. Falchetti A,
    3. Azzoni C,
    4. D'Adda T,
    5. Canavese G,
    6. Guariglia A,
    7. Santini D,
    8. Tomassetti P &
    9. Brandi ML

    1997 Aggressive forms of gastric neuroendocrine tumors in multiple endocrine neoplasia type I. American Journal of Surgical Pathology 21 1075–1082. doi:10.1097/00000478-199709000-00012.
13. ↵
    1. Bordi C,
    2. D'Adda T,
    3. Azzoni C,
    4. Canavese G &
    5. Brandi ML

    1998 Gastrointestinal endocrine tumors: recent developments. Endocrine Pathology 9 99–115. doi:10.1007/BF02782603.
14. ↵
    1. Bostwick DG,
    2. Quan R,
    3. Hoffman AR,
    4. Webber RJ,
    5. Chang JK &
    6. Bensch KG

    1984 Growth-hormone-releasing factor immunoreactivity in human endocrine tumors. American Journal of Pathology 117 167–170.
15. ↵
    1. Brenner B,
    2. Tang LH,
    3. Klimstra DS &
    4. Kelsen DP

    2004 Small-cell carcinomas of the gastrointestinal tract: a review. Journal of Clinical Oncology 22 2730–2739. doi:10.1200/JCO.2004.09.075.
16. ↵
    1. Brenner B,
    2. Tang LH,
    3. Shia J,
    4. Klimstra DS &
    5. Kelsen DP

    2007 Small cell carcinomas of the gastrointestinal tract: clinicopathological features and treatment approach. Seminars in Oncology 34 43–50. doi:10.1053/j.seminoncol.2006.10.022.
17. ↵
    1. Burke AP,
    2. Sobin LH,
    3. Federspiel BH,
    4. Shekitka KM &
    5. Helwig EB

    1990 Carcinoid tumors of the duodenum. A clinicopathologic study of 99 cases. Archives of Pathology & Laboratory Medicine 114 700–704.
18. ↵
    1. Burke AP,
    2. Shekitka KM &
    3. Sobin LH

    1991 Small cell carcinomas of the large intestine. American Journal of Clinical Pathology 95 315–321.
19. ↵
    1. Burke AP,
    2. Thomas RM,
    3. Elsayed AM &
    4. Sobin LH

    1997 Carcinoids of the jejunum and ileum. An immunohistochemical and clinicopathologic study of 167 cases. Cancer 79 1086–1093. doi:10.1002/(SICI)1097-0142(19970315)79:6<1086::AID-CNCR5>3.0.CO;2-E.
20. ↵
    1. Capella C,
    2. Polak JM,
    3. Buffa R,
    4. Tapia FJ,
    5. Heitz P,
    6. Usellini L,
    7. Bloom SR &
    8. Solcia E

    1983 Morphologic patterns and diagnostic criteria of VIP-producing endocrine tumors. A histologic, histochemical, ultrastructural and biochemical study of 32 cases. Cancer 52 1860–1874. doi:10.1002/1097-0142(19831115)52:10<1860::AID-CNCR2820521017>3.0.CO;2-F.
21. ↵
    1. Capella C,
    2. Riva C,
    3. Rindi G,
    4. Sessa F,
    5. Usellini L,
    6. Chiaravalli A,
    7. Carnevali L &
    8. Solcia E

    1991 Histopathology, hormone products, and clinicopathological profile of endocrine tumors of the upper small intestine: a study of 44 cases. Endocrine Pathology 2 92–110. doi:10.1007/BF02915331.
22. ↵
    1. Capella C,
    2. Heitz PU,
    3. Höfler H,
    4. Solcia E &
    5. Klöppel G

    1995 Revised classification of neuroendocrine tumours of the lung, pancreas and gut. Virchows Archiv 425 547–560. doi:10.1007/BF00199342.
23. ↵
    1. Capella C,
    2. La Rosa S &
    3. Solcia E

    1997 Criteria for malignancy in pancreatic endocrine tumors. Endocrine Pathology 8 87–90. doi:10.1007/BF02739937.
24. ↵
    1. Hamilton SR &
    2. Aaltonen LA

    1. Capella C,
    2. Solcia E,
    3. Sobin LH &
    4. Arnold R

    2000 Endocrine tumours of the oesophagus. In Pathology and Genetics. Tumours of the Digestive System. WHO Classification of Tumours, Hamilton SR & Aaltonen LA. Lyon: IARC Press.
25. ↵
    1. Clark ES &
    2. Carney JA

    1984 Pancreatic islet cell tumor associated with Cushing's syndrome. American Journal of Surgical Pathology 8 917–924. doi:10.1097/00000478-198412000-00004.
26. ↵
    1. Crafa P,
    2. Milione M,
    3. Azzhoni C,
    4. Pilato FP,
    5. Pizzi S &
    6. Bordi C

    2003 Pleomorph poorly differentiated endocrine carcinoma of the rectum. Virchows Archiv 442 605–610.
27. ↵
    1. Crain EL &
    2. Thorn GW

    1949 Functioning pancreatic islet cell adenomas: a review of the literature and presentation of two new differential tests. Medicine 28 427–447. doi:10.1097/00005792-194912000-00003.
28. ↵
    1. Dayal Y,
    2. Lin HD,
    3. Tallberg K,
    4. Reichlin S,
    5. DeLellis RA &
    6. Wolfe HJ

    1986a Immunocytochemical demonstration of growth hormone-releasing factor in gastrointestinal and pancreatic endocrine tumors. American Journal of Clinical Pathology 85 13–20.
29. ↵
    1. Dayal Y,
    2. Tallberg KA,
    3. Nunnemacher G,
    4. DeLellis RA &
    5. Wolfe HJ

    1986b Duodenal carcinoids in patients with and without neurofibromatosis. A comparative study. American Journal of Surgical Pathology 10 348–357. doi:10.1097/00000478-198605000-00007.
30. ↵
    1. Debelenko LV,
    2. Emmert-Buck MR,
    3. Zhuang Z,
    4. Epshteyn E,
    5. Moskaluk CA,
    6. Jensen RT,
    7. Liotta LA &
    8. Lubensky IA

    1997 The multiple endocrine neoplasia type I gene locus is involved in the pathogenesis of type II gastric carcinoids. Gastroenterology 113 773–781. doi:10.1016/S0016-5085(97)70171-9.
31. ↵
    1. Donow C,
    2. Pipeleers-Marichal M,
    3. Schröder S,
    4. Stamm B,
    5. Heitz PU &
    6. Klöppel G

    1991 Surgical pathology of gastrinoma. Site, size, multicentricity, association with multiple endocrine neoplasia type 1, and malignancy. Cancer 68 1329–1334. doi:10.1002/1097-0142(19910915)68:6<1329::AID-CNCR2820680624>3.0.CO;2-7.
32. ↵
    1. Drucker DJ,
    2. Asa SL,
    3. Henderson J &
    4. Goltzman D

    1989 The parathyroid hormone-like peptide gene is expressed in the normal and neoplastic human endocrine pancreas. Molecular Endocrinology 3 1589–1595. doi:10.1210/mend-3-10-1589.
33. ↵
    1. Ekeblad S,
    2. Skogseid B,
    3. Dunder K,
    4. Oberg K &
    5. Eriksson B

    2008 Prognostic factors and survival in 324 patients with pancreatic endocrine tumor treated at a single institution. Clinical Cancer Research 14 7798–7803. doi:10.1158/1078-0432.CCR-08-0734.
34. ↵
    1. Eriksson B,
    2. Klöppel G,
    3. Krenning E,
    4. Ahlman H,
    5. Plöckinger U,
    6. Wiedenmann B,
    7. Arnold R,
    8. Auernhammer C,
    9. Körner M,
    10. Rindi G
    11. et al.

    2008 Consensus guidelines for the management of patients with digestive neuroendocrine tumors-well-differentiated jejunal–ileal tumor/carcinoma. Neuroendocrinology 87 8–19. doi:10.1159/000111034.
35. ↵
    1. Fischer L,
    2. Kleeff J,
    3. Esposito I,
    4. Hinz U,
    5. Zimmermann A,
    6. Friess H &
    7. Büchler MW

    2008 Clinical outcome and long-term survival in 118 consecutive patients with neuroendocrine tumours of the pancreas. British Journal of Surgery 95 627–635. doi:10.1002/bjs.6051.
36. ↵
    1. Fung JW &
    2. Lam KS

    1995 Neurofibromatosis and insulinoma. Postgraduate Medical Journal 71 485–486. doi:10.1136/pgmj.71.838.485.
37. ↵
    1. Garbrecht N,
    2. Anlauf M,
    3. Schmitt A,
    4. Henopp T,
    5. Sipos B,
    6. Raffel A,
    7. Eisenberger CF,
    8. Knoefel WT,
    9. Pavel M,
    10. Fottner C
    11. et al.

    2008 Somatostatin-producing neuroendocrine tumors of the duodenum and pancreas: incidence, types, biological behavior, association with inherited syndromes, and functional activity. Endocrine-Related Cancer 15 229–241. doi:10.1677/ERC-07-0157.
38. ↵
    1. van Heerden JA,
    2. Edis AJ &
    3. Service FJ

    1979 The surgical aspects of insulinomas. Annals of Surgery 189 677–682. doi:10.1097/00000658-197906000-00002.
39. ↵
    1. Heitz PU,
    2. Klöppel G,
    3. Polak JM &
    4. Staub JJ

    1981 Ectopic hormone production by endocrine tumors: localization of hormones at the cellular level by immunocytochemistry. Cancer 48 2029–2037. doi:10.1002/1097-0142(19811101)48:9<2029::AID-CNCR2820480920>3.0.CO;2-N.
40. ↵
    1. DeLellis RA,
    2. Lloyd RV,
    3. Heitz PU &
    4. Eng C

    1. Heitz PU,
    2. Komminoth P,
    3. Perren A,
    4. Klimstra DS,
    5. Dayal Y,
    6. Bordi C,
    7. LeChago J,
    8. Centeno BA &
    9. Klöppel G

    2004 Pancreatic endocrine tumours: introduction. In Pathology and Genetics: Tumours of Endocrine Organs. WHO Classification of Tumors, pp 177–182. Eds DeLellis RA, Lloyd RV, Heitz PU & Eng C. Lyon: IARC Press.
41. ↵
    1. Henopp T,
    2. Anlauf M,
    3. Schmitt A,
    4. Schlenger R,
    5. Zalatnai A,
    6. Couvelard A,
    7. Ruszniewski P,
    8. Schaps KP,
    9. Jonkers YM,
    10. Speel EJ
    11. et al.

    2009 Glucagon cell adenomatosis: a newly recognized disease of the endocrine pancreas. Journal of Clinical Endocrinology and Metabolism 94 213–217. doi:10.1210/jc.2008-1300.
42. ↵
    1. Higgins GA,
    2. Recant L &
    3. Fischman AB

    1979 The glucagonoma syndrome: surgically curable diabetes. American Journal of Surgery 137 142–148. doi:10.1016/0002-9610(79)90025-4.
43. ↵
    1. Horenstein MG,
    2. Erlandson RA,
    3. Gonzalez-Cueto DM &
    4. Rosai J

    1998 Presacral carcinoid tumors. Report of three cases and review of the literature. American Journal of Surgical Pathology 22 251–255. doi:10.1097/00000478-199802000-00015.
44. ↵
    Hruban RH, Bishop Pitman M & Klimstra DS 2007 Tumors of the pancreas. In AFIP Atlas of Tumor Pathology, 4th series, fascicle 6. Washington, DC, USA: Armed Forces Institute of Pathology.
45. ↵
    1. Go VLW,
    2. DiMagno EP,
    3. Gardner JD,
    4. Lebenthal E,
    5. Reber HA &
    6. Scheele GA

    1. Jensen RT &
    2. Gardner JD

    1993 Gastrinoma. In The Pancreas: Biology, Pathobiology and Disease, pp 931–978. Eds Go VLW, DiMagno EP, Gardner JD, Lebenthal E, Reber HA & Scheele GA. New York: Raven Press.
46. ↵
    1. Jensen RT,
    2. Niederle B,
    3. Mitry E,
    4. Ramage JK,
    5. Steinmuller T,
    6. Lewington V,
    7. Scarpa A,
    8. Sundin A,
    9. Perren A,
    10. Gross D
    11. et al.

    2006a Gastrinoma (duodenal and pancreatic). Neuroendocrinology 84 173–182. doi:10.1159/000098009.
47. ↵
    1. Jensen RT,
    2. Rindi G,
    3. Arnold R,
    4. Lopes JM,
    5. Brandi ML,
    6. Bechstein WO,
    7. Christ E,
    8. Taal BG,
    9. Knigge U,
    10. Ahlman H
    11. et al.

    2006b Well-differentiated duodenal tumor/carcinoma (excluding gastrinomas). Neuroendocrinology 84 165–172. doi:10.1159/000098008.
48. ↵
    1. Kao PC,
    2. Klee GG,
    3. Taylor RL &
    4. Heath H III.

    1990 Parathyroid hormone-related peptide in plasma of patients with hypercalcemia and malignant lesions. Mayo Clinic Proceedings 65 1399–1407.
49. ↵
    1. Kapran Y,
    2. Bauersfeld J,
    3. Anlauf M,
    4. Sipos B &
    5. Klöppel G

    2006 Multihormonality and entrapment of islets in pancreatic endocrine tumors. Virchows Archiv 448 394–398. doi:10.1007/s00428-005-0147-4.
50. ↵
    1. Kent RB III.,
    2. van Heerden JA &
    3. Weiland LH

    1981 Nonfunctioning islet cell tumours. Annals of Surgery 193 185–190. doi:10.1097/00000658-198102000-00010.
51. ↵
    1. Klöppel G &
    2. Clemens A

    1996 The biological relevance of gastric neuroendocrine tumors. Yale Journal of Biology and Medicine 69 69–74.
52. Klöppel G & Heitz PU 2007 Tumors of the endocrine pancreas. In: Diagnostic Histopathology of Tumors, vol 2, 3rd Edn, pp 1123–1137. Ed. CD Fletcher. Philadelphia, PA, USA: Churchill Livingstone, Elsevier.
53. ↵
    1. Klöppel G,
    2. Rindi G,
    3. Anlauf M,
    4. Perren A &
    5. Komminoth P

    2007 Site-specific biology and pathology of gastroenteropancreatic neuroendocrine tumors. Virchows Archiv 451 (Suppl 1) S9–S27. doi:10.1007/s00428-007-0461-0.
54. ↵
    1. Klöppel G,
    2. Couvelard A,
    3. Perren A,
    4. Komminoth P,
    5. McNicole AM,
    6. Nilsson O,
    7. Scarpa A,
    8. Scoazec JY,
    9. Wiedenmann B,
    10. Papotti M
    11. et al.

    2009 ENETS Consensus Guidelines for the Standards of Care in Neuroendocrine Tumors: towards a standardized approach to the diagnosis of gastroenteropancreatic neuroendocrine tumors and their prognostic stratification. Neuroendocrinology 90 162–166. doi:10.1159/000182196.
55. ↵
    1. Klöppel G,
    2. Rindi G,
    3. Perren A,
    4. Komminoth P &
    5. Klimstra DS

    2010 The ENETS and AJCC/UICC TNM classifications of the neuroendocrine tumors of the gastrointestinal tract and the pancreas: a statement. Virchows Archiv 456 595–597. doi:10.1007/s00428-010-0924-6.
56. ↵
    1. Konukiewitz B,
    2. Enosawa T &
    3. Klöppel G

    2011 Glucagon expression in cystic pancreatic neuroendocrine neoplasms: an immunohistochemical analysis. Virchows Archiv 458 47–53. doi:10.1007/s00428-010-0985-6.
57. ↵
    1. Krejs GJ,
    2. Orci L,
    3. Conlon JM,
    4. Ravazzola M,
    5. Davis GR,
    6. Raskin P,
    7. Collins SM,
    8. McCarthy DM,
    9. Baetens D,
    10. Rubenstein A
    11. et al.

    1979 Somatostatinoma syndrome. Biochemical, morphologic and clinical features. New England Journal of Medicine 301 285–292. doi:10.1056/NEJM197908093010601.
58. ↵
    1. La Rosa S,
    2. Klersy C,
    3. Uccella S,
    4. Dainese L,
    5. Albarello L,
    6. Sonzogni A,
    7. Doglioni C,
    8. Capella C &
    9. Solcia E

    2009 Improved histologic and clinicopathologic criteria for prognostic evaluation of pancreatic endocrine tumors. Human Pathology 40 30–40. doi:10.1016/j.humpath.2008.06.005.
59. ↵
    1. Larsson LI,
    2. Hirsch MA,
    3. Holst JJ,
    4. Ingemansson S,
    5. Kuhl C,
    6. Jensen SL,
    7. Lundquist G,
    8. Rehfeld JF &
    9. Schwartz TW

    1977 Pancreatic somatostatinoma. Clinical features and physiological implications. Lancet 1 666–668. doi:10.1016/S0140-6736(77)92113-4.
60. ↵
    1. Ligneau B,
    2. Lombard-Bohas C,
    3. Partensky C,
    4. Valette PJ,
    5. Calender A,
    6. Dumortier J,
    7. Gouysse G,
    8. Boulez J,
    9. Napoleon B,
    10. Berger F
    11. et al.

    2001 Cystic endocrine tumors of the pancreas: clinical, radiologic, and histopathologic features in 13 cases. American Journal of Surgical Pathology 25 760doi:10.1097/00000478-200106000-00006.
61. ↵
    1. Lloyd RV

    2003 Practical markers used in the diagnosis of neuroendocrine tumors. Endocrine Pathology 14 293–301. doi:10.1385/EP:14:4:293.
62. ↵
    1. Lubensky IA,
    2. Pack S,
    3. Ault D,
    4. Vortmeyer AO,
    5. Libutti SK,
    6. Choyke PL,
    7. Walther MM,
    8. Linehan WM &
    9. Zhuang Z

    1998 Multiple neuroendocrine tumors of the pancreas in von Hippel–Lindau disease patients: histopathological and molecular genetic analysis. American Journal of Pathology 153 223–231. doi:10.1016/S0002-9440(10)65563-0.
63. ↵
    1. MacGillivray DC,
    2. Heaton RB,
    3. Rushin JM &
    4. Cruess DF

    1992 Distant metastasis from a carcinoid tumor of the appendix less than one centimeter in size. Surgery 111 466–471.
64. ↵
    1. Makhlouf HR,
    2. Burke AP &
    3. Sobin LH

    1999 Carcinoid tumors of the ampulla of Vater. A comparison with duodenal carcinoid tumors. Cancer 85 1241–1249. doi:10.1002/(SICI)1097-0142(19990315)85:6<1241::AID-CNCR5>3.0.CO;2-4.
65. ↵
    1. Martin EN &
    2. Potet F

    1974 Pathology of endocrine tumors of the GI tract. Clinical Gastroenterology 3 511–532.
66. ↵
    1. Maru DP,
    2. Khurana H,
    3. Rashid A,
    4. Correa AM,
    5. Anandasabapathy S,
    6. Krishnan S,
    7. Komaki R,
    8. Ajani JA,
    9. Swisher SG &
    10. Hostetter WL

    2008 Retrospective study of clinicopathologic features and prognosis of high-grade neuroendocrine carcinoma of the esophagus. American Journal of Surgical Pathology 32 1404–1411. doi:10.1097/PAS.0b013e31816bf41f.
67. ↵
    1. McCall CM,
    2. Shi C,
    3. Klein AP,
    4. Konukiewitz B,
    5. Edil BH,
    6. Ellison TA,
    7. Wolfgang CL,
    8. Schulick RD,
    9. Klöppel G &
    10. Hruban RH

    2011 Serotonin expression in pancreatic neuroendocrine tumors correlates with a trabecular histologic pattern and large duct involvement. Human Pathology[in press].
68. ↵
    1. McGory ML,
    2. Maggard MA,
    3. Kang H,
    4. O'Connell JB &
    5. Ko CY

    2005 Malignancies of the appendix: beyond case series reports. Diseases of the Colon and Rectum 48 2264–2271. doi:10.1007/s10350-005-0196-4.
69. ↵
    1. Melmed S,
    2. Yamashita S,
    3. Kovacs K,
    4. Ong J,
    5. Rosenblatt S &
    6. Braunstein G

    1987 Cushing's syndrome due to ectopic proopiomelanocortin gene expression by islet cell carcinoma of the pancreas. Cancer 59 772–778. doi:10.1002/1097-0142(19870215)59:4<772::AID-CNCR2820590418>3.0.CO;2-H.
70. ↵
    1. Modlin IM,
    2. Kidd M,
    3. Latich I,
    4. Zikusoka MN &
    5. Shapiro MD

    2005 Current status of gastrointestinal carcinoids. Gastroenterology 128 1717–1751. doi:10.1053/j.gastro.2005.03.038.
71. ↵
    1. Moyana TN

    1989 Carcinoid tumors arising from Meckel's diverticulum. A clinical, morphologic, and immunohistochemical study. American Journal of Clinical Pathology 91 52–56.
72. ↵
    1. Nassar H,
    2. Albores-Saavedra J &
    3. Klimstra DS

    2005 High-grade neuroendocrine carcinoma of the ampulla of Vater. A clinicopathologic and immunohistochemical analysis of 14 cases. American Journal of Surgical Pathology 29 588–594. doi:10.1097/01.pas.0000157974.05397.4f.
73. ↵
    1. Niederle MB,
    2. Hackl M,
    3. Kaserer K &
    4. Niederle B

    2010 Gastroenteropancreatic neuroendocrine tumours: the current incidence and staging based on the WHO and European Neuroendocrine Tumour Society classification: an analysis based on prospectively collected parameters. Endocrine-Related Cancer 17 909–918. doi:10.1677/ERC-10-0152.
74. ↵
    1. Oberhelman HA &
    2. Nelsen TS

    1964 Surgical consideration in the management of ulcerogenic tumors of the pancreas and duodenum. American Journal of Surgery 108 132–141. doi:10.1016/0002-9610(64)90002-9.
75. ↵
    1. Oberndorfer S

    1907 Karzinoide Tumoren des Dünndarms. Frankfurter Zeitschrift för Pathologie 1 425–432.
76. ↵
    1. Mazzaferri EL &
    2. Samaan NA

    1. O'Dorisio TM,
    2. Ellison EC,
    3. Johnson JA &
    4. Mazzaferri EL

    1993 Multiple endocrine neoplasia and gastrinoma. In Endocrine Tumors, pp 484–496. Eds Mazzaferri EL & Samaan NA. Boston: Blackwell Scientific Publications.
77. ↵
    1. Ooi A,
    2. Ota M,
    3. Katsuda S,
    4. Nakanishi I,
    5. Sugawara H &
    6. Takahashi I

    1995 An unusual case of multiple gastric carcinoids associated with diffuse endocrine cell hyperplasia and parietal cell hypertrophy. Endocrine Pathology 6 229–237. doi:10.1007/BF02739887.
78. 1. Ordóñez NG,
    2. Manning JT Jr. &
    3. Raymond AK

    1985 Argentaffin endocrine carcinoma (carcinoid) of the pancreas with concomitant breast metastasis: an immunohistochemical and electron microscopic study. Human Pathology 16 746–751. doi:10.1016/S0046-8177(85)80164-7.
79. ↵
    1. Pape UF,
    2. Jann H,
    3. Muller-Nordhorn J,
    4. Bockelbrink A,
    5. Berndt U,
    6. Willich SN,
    7. Koch M,
    8. Röcken C,
    9. Rindi G &
    10. Wiedenmann B

    2008 Prognostic relevance of a novel TNM classification system for upper gastroenteropancreatic neuroendocrine tumors. Cancer 113 256–265. doi:10.1002/cncr.23549.
80. ↵
    1. Parkes SE,
    2. Muir KR,
    3. al Sheyyab M,
    4. Cameron AH,
    5. Pincott JR,
    6. Raafat F &
    7. Mann JR

    1993 Carcinoid tumours of the appendix in children 1957–1986: incidence, treatment and outcome. British Journal of Surgery 80 502–504. doi:10.1002/bjs.1800800433.
81. ↵
    1. Perigny M,
    2. Hammel P,
    3. Corcos O,
    4. Larochelle O,
    5. Giraud S,
    6. Richard S,
    7. Sauvanet A,
    8. Belghiti J,
    9. Ruszniewski P,
    10. Bedossa P
    11. et al.

    2009 Pancreatic endocrine microadenomatosis in patients with von Hippel–Lindau disease: characterization by VHL/HIF pathway proteins expression. American Journal of Surgical Pathology 33 739–748. doi:10.1097/PAS.0b013e3181967992.
82. ↵
    1. Perren A,
    2. Anlauf M,
    3. Henopp T,
    4. Rudolph T,
    5. Schmitt A,
    6. Raffel A,
    7. Gimm O,
    8. Weihe E,
    9. Knoefel WT,
    10. Dralle H
    11. et al.

    2007 Multiple endocrine neoplasia type 1 (MEN1): loss of one MEN1 allele in tumors and monohormonal endocrine cell clusters but not in islet hyperplasia of the pancreas. Journal of Clinical Endocrinology and Metabolism 92 1118–1128. doi:10.1210/jc.2006-1944.
83. ↵
    1. Pipeleers D,
    2. Couturier E,
    3. Gepts W,
    4. Reynders J &
    5. Somers G

    1983 Five cases of somatostatinoma: clinical heterogeneity and diagnostic usefulness of basal and tolbutamide-induced hypersomatostatinemia. Journal of Clinical Endocrinology and Metabolism 56 1236–1242. doi:10.1210/jcem-56-6-1236.
84. ↵
    1. Pipeleers-Marichal M,
    2. Somers G,
    3. Willems G,
    4. Foulis A,
    5. Imrie C,
    6. Bishop AE,
    7. Polak JM,
    8. Häcki WH,
    9. Stamm B,
    10. Heitz PU
    11. et al.

    1990 Gastrinomas in the duodenums of patients with multiple endocrine neoplasia type 1 and the Zollinger–Ellison syndrome. New England Journal of Medicine 322 723–727. doi:10.1056/NEJM199003153221103.
85. ↵
    1. Pipeleers-Marichal M,
    2. Donow C,
    3. Heitz PU &
    4. Klöppel G

    1993 Pathologic aspects of gastrinomas in patients with Zollinger–Ellison syndrome with and without multiple endocrine neoplasia type I. World Journal of Surgery 17 481–488. doi:10.1007/BF01655107.
86. ↵
    1. Plöckinger U &
    2. Wiedenmann B

    2007 Treatment of gastroenteropancreatic neuroendocrine tumors. Virchows Archiv 451 (Supplement 1) S71–S80. doi:10.1007/s00428-007-0446-z.
87. ↵
    1. Prinz RA,
    2. Dorsch TR &
    3. Lawrence AM

    1981 Clinical aspects of glucagon-producing islet cell tumors. American Journal of Gastroenterology 76 125–131.
88. ↵
    1. Pulitzer M,
    2. Xu R,
    3. Suriawinata AA,
    4. Waye JD &
    5. Harpaz N

    2006 Microcarcinoids in large intestinal adenomas. American Journal of Surgical Pathology 30 1531–1536. doi:10.1097/01.pas.0000213295.88778.00.
89. ↵
    1. Rappel S,
    2. Altendorf-Hofmann A &
    3. Stolte M

    1995 Prognosis of gastric carcinoid tumours. Digestion 56 455–462. doi:10.1159/000201276.
90. ↵
    1. Rindi G &
    2. Klöppel G

    2004 Endocrine tumors of the gut and pancreas tumor biology and classification. Neuroendocrinology 80 (Supplement 1) 12–15. doi:10.1159/000080733.
91. ↵
    1. Rindi G,
    2. Luinetti O,
    3. Cornaggia M,
    4. Capella C &
    5. Solcia E

    1993 Three subtypes of gastric argyrophil carcinoid and the gastric neuroendocrine carcinoma: a clinicopathologic study. Gastroenterology 104 994–1006.
92. ↵
    1. Rindi G,
    2. Klöppel G,
    3. Ahlman H,
    4. Caplin M,
    5. Couvelard A,
    6. de Herder WW,
    7. Eriksson B,
    8. Falchetti A,
    9. Falconi M,
    10. Komminoth P
    11. et al.

    2006 TNM staging of foregut (neuro)endocrine tumors: a consensus proposal including a grading system. Virchows Archiv 449 395–401. doi:10.1007/s00428-006-0250-1.
93. ↵
    1. Rindi G,
    2. Klöppel G,
    3. Couvelard A,
    4. Komminoth P,
    5. Koerner M,
    6. Lopes J,
    7. McNicol AM,
    8. Nilsson O,
    9. Perren A,
    10. Scarpa A
    11. et al.

    2007 TNM staging of midgut and hindgut (neuro)endocrine tumors: a consensus proposal including a grading system. Virchows Archiv 451 757–762. doi:10.1007/s00428-007-0452-1.
94. ↵
    1. Bosman FT,
    2. Carneiro F,
    3. Hruban RH &
    4. Theise N

    1. Rindi G,
    2. Arnold R,
    3. Bosman FT,
    4. Capella C,
    5. Klimstra DS,
    6. Klöppel G,
    7. Komminoth P &
    8. Solcia E

    2010 Nomenclature and classification of neuroendocrine neoplasms of the digestive system. In WHO Classification of Tumours of the Digestive System, pp 13–14. Eds Bosman FT, Carneiro F, Hruban RH & Theise N. Lyon: IARC Press.
95. ↵
    1. Rosenberg JM &
    2. Welch JP

    1985 Carcinoid tumors of the colon. A study of 72 patients. American Journal of Surgery 149 775–779. doi:10.1016/S0002-9610(85)80184-7.
96. ↵
    1. Rossi G,
    2. Valli R,
    3. Bertolini F,
    4. Sighinolfi P,
    5. Losi L,
    6. Cavazza A,
    7. Rivasi F &
    8. Luppi G

    2003 Does mesoappendix infiltration predict a worse prognosis in incidental neuroendocrine tumors of the appendix? A clinicopathologic, immunohistochemical, and molecular study of a hitherto unreported tumor. American Journal of Surgical Pathology 28 1233–1236. doi:10.1097/01.pas.0000128666.89191.48.
97. ↵
    1. Ruttmann E,
    2. Klöppel G,
    3. Bommer G,
    4. Kiehn M &
    5. Heitz PU

    1980 Pancreatic glucagonoma with and without syndrome. Immunocytochemical study of 5 tumour cases and review of the literature. Virchows Archiv. A, Pathological Anatomy and Histology 388 51–67. doi:10.1007/BF00430676.
98. ↵
    1. Sano T,
    2. Asa SL &
    3. Kovacs K

    1988 Growth hormone-releasing hormone-producing tumors: clinical, biochemical, and morphological manifestations. Endocrine Reviews 9 357–373. doi:10.1210/edrv-9-3-357.
99. ↵
    1. Scarpa A,
    2. Mantovani W,
    3. Capelli P,
    4. Beghelli S,
    5. Boninsegna L,
    6. Bettini R,
    7. Panzuto F,
    8. Pederzoli P,
    9. delle Fave G &
    10. Falconi M

    2010 Pancreatic endocrine tumors: improved TNM staging and histopathological grading permit a clinically efficient prognostic stratification of patients. Modern Pathology 23 824–833. doi:10.1038/modpathol.2010.58.
100. ↵
     1. Scherübl H,
     2. Cadiot G,
     3. Jensen RT,
     4. Rösch T,
     5. Stölzel U &
     6. Klöppel G

     2010 Neuroendocrine tumors of the stomach (gastric carcinoids) are on the rise: small tumors, small problems? Endoscopy 42 1–8. doi:10.1055/s-0030-1255564.
101. ↵
     1. Schmitt AM,
     2. Anlauf M,
     3. Rousson V,
     4. Schmid S,
     5. Kofler A,
     6. Riniker F,
     7. Bauersfeld J,
     8. Barghorn A,
     9. Probst N,
     10. Moch H
     11. et al.

     2007 WHO 2004 criteria and CK19 are reliable prognostic markers in pancreatic endocrine tumors. American Journal of Surgical Pathology 31 1677–1682. doi:10.1097/PAS.0b013e31805f675d.
102. ↵
     1. Service FJ,
     2. McMahon MM,
     3. O'Brien PC &
     4. Ballard DJ

     1991 Functioning insulinoma – incidence, recurrence, and long-term survival of patients: a 60-year study. Mayo Clinic Proceedings 66 711–719.
103. ↵
     1. Sessa F,
     2. Arcidiaco M,
     3. Valenti L,
     4. Solcia M,
     5. Di Maggio E &
     6. Solcia E

     1998 Metastatic psammomatous somatostatinoma of the pancreas causing severe ketoacedotic diabetes cured by surgery. Endocrine Pathology 8 327–333. doi:10.1007/BF02739935.
104. ↵
     Sobin LH, Gospodarowicz MK & Wittekind C 2009 UICC: TNM classification of malignant tumours, 7th edn. Oxford, UK: Wiley-Blackwell.
105. ↵
     1. Soga J

     1997 Carcinoids of the recum: an evaluation of 1271 reported cases. Surgery Today 27 112–119. doi:10.1007/BF02385898.
106. ↵
     1. Soga J

     1998 Carcinoids of the colon and ileocecal region: a statistical evaluation of 363 cases collected from the literature. Journal of Experimental & Clinical Cancer Research 17 139–148.
107. ↵
     1. Soga J,
     2. Yakuwa Y &
     3. Osaka M

     1998 Insulinoma/hypoglycemic syndrome: a statistical evaluation of 1085 reported cases of a Japanese series. Journal of Experimental & Clinical Cancer Research 17 379–388.
108. ↵
     1. Solcia E,
     2. Capella C,
     3. Fiocca R,
     4. Cornaggia M &
     5. Bosi F

     1989 The gastroenteropancreatic endocrine system and related tumors. Gastroenterology Clinics of North America 18 671–693.
109. ↵
     Solcia E, Capella C & Klöppel G 1997 Tumors of the pancreas. In AFIP Atlas of Tumor Pathology, 3rd series, fascicle 20. Washington, DC: Armed Forces Institute of Pathology.
110. ↵
     Solcia E, Klöppel G & Sobin LH 2000 Histological typing of endocrine tumours. In WHO International Histological Classification of Tumours, 2nd Edn. Berlin, Germany: Springer.
111. ↵
     1. Stabile BE,
     2. Morrow DJ &
     3. Passaro E Jr.

     1984 The gastrinoma triangle: operative implications. American Journal of Surgery 147 25–31. doi:10.1016/0002-9610(84)90029-1.
112. ↵
     1. Stamm B,
     2. Hedinger CE &
     3. Saremaslani P

     1986 Duodenal and ampullary carcinoid tumors. A report of 12 cases with pathological characteristics, polypeptide content and relation to the MEN 1 syndrome and von Recklingshausen's disease (neurofibromatosis). Virchows Archiv. A, Pathological Anatomy and Histology 408 475–489. doi:10.1007/BF00705301.
113. ↵
     1. Dayal Y

     1. Stamm B,
     2. Häcki WH,
     3. Klöppel G &
     4. Heitz PU

     1991 Gastrin-producing tumors and the Zollinger–Ellison syndrome. In Endocrine Pathology of the Gut and Pancreas, pp 155–194. Ed. Dayal Y. Boca Raton: CRC Press.
114. ↵
     1. Stefanini P,
     2. Carboni M,
     3. Patrassi N &
     4. Basoli A

     1974 Beta-islet cell tumors of the pancreas: results of a study on 1,067 cases. Surgery 75 597–609.
115. ↵
     1. Stinner B,
     2. Kisker O,
     3. Zielke A &
     4. Rothmund M

     1996 Surgical management for carcinoid tumors of small bowel, appendix, colon, and rectum. World Journal of Surgery 20 183–188. doi:10.1007/s002689900028.
116. ↵
     1. Taccagni GL,
     2. Carlucci M,
     3. Sironi M,
     4. Cantaboni A &
     5. Di Carlo V

     1986 Duodenal somatostatinoma with psammoma bodies: an immunohistochemical and ultrastructural study. American Journal of Gastroenterology 81 33–37.
117. ↵
     1. Theunissen P,
     2. Fickers M &
     3. Goei R

     2001 Primary large cell neuroendocrine carcinoma of the presacral region. Journal of Clinical Pathology 54 880–882. doi:10.1136/jcp.54.11.880.
118. ↵
     1. Vinik AI,
     2. Strodel WE,
     3. Eckhauser FE,
     4. Moattari AR &
     5. Lloyd R

     1987 Somatostatinomas, PPomas, neurotensinomas. Seminars in Oncology 14 263–281.
119. ↵
     1. Walter T,
     2. Hervieu V,
     3. Adham M,
     4. Gincul R,
     5. Poncet G,
     6. Pilleul F,
     7. Chayvialle JA,
     8. Partensky C,
     9. Lombard-Bohas C &
     10. Scoazec JY

     2011 Primary neuroendocrine tumors of the main pancreatic duct: a rare entity. Virchows Archiv 485 537–546. doi:10.1007/s00428-011-1067-0.
120. ↵
     1. West NE,
     2. Wise PE,
     3. Herline AJ,
     4. Muldoon RL,
     5. Chopp WV &
     6. Schwartz DA

     2007 Carcinoid tumors are 15 times more common in patients with Crohn's disease. Inflammatory Bowel Diseases 13 1129–1134. doi:10.1002/ibd.20172.
121. ↵
     1. Wilander E,
     2. El-Salhy M,
     3. Willén T &
     4. Grimelius L

     1981 Immunocytochemistry and electron microscopy of an argentaffin endocrine tumor of the pancreas. Virchows Archiv. A, Pathological Anatomy and Histology 392 263–269. doi:10.1007/BF02155664.
122. ↵
     1. Williams ED &
     2. Sandler M

     1963 The classification of carcinoid tumours. Lancet I 238–239. doi:10.1016/S0140-6736(63)90951-6.
123. ↵
     1. Yagihashi S,
     2. Yagihashi N &
     3. Nagai K

     1992 Cystic pancreatic glucagonoma in contact with insulinoma found in a hypoglycemic patient. Pathology, Research and Practice 188 751–756.
124. ↵
     1. Yantiss RK,
     2. Odze RD,
     3. Farraye FA &
     4. Rosenberg AE

     2003 Solitary versus multiple carcinoid tumors of the ileum. A clinical and pathologic review of 68 cases. American Journal of Surgical Pathology 27 811–817. doi:10.1097/00000478-200306000-00013.
125. ↵
     1. Zamboni G,
     2. Franzin G,
     3. Bonetti F,
     4. Scarpa A,
     5. Chilosi M,
     6. Colombari R,
     7. Menestrina F,
     8. Pea M,
     9. Iacono C,
     10. Serio G
     11. et al.

     1990 Small-cell neuroendocrine carcinoma of the ampullary region. A clinical and pathologic review of 68 cases. American Journal of Surgical Pathology 14 703–713. doi:10.1097/00000478-199008000-00001.
126. ↵
     1. Zhou C,
     2. Dhall D,
     3. Nissen NN,
     4. Chen CR &
     5. Yu R

     2009 Homozygous P86S mutation of the human glucagon receptor is associated with hyperglucagonemia, alpha cell hyperplasia, and islet cell tumor. Pancreas 38 941–946. doi:10.1097/MPA.0b013e3181b2bb03.